Cybin LOGO.png
Psychedelics Experiencing Renaissance, Offer Tremendous Treatment Potential
October 16, 2020 08:30 ET | Cybin Corp.
NEW YORK, Oct. 16, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio -- Cybin Corp. announces the availability of a broadcast titled, “Multi-Billion-Dollar Market Forecast in Psychedelic Therapeutics.” ...
Cybin LOGO.png
Psychedelic Drugs Offering New Hope for Treatment of Debilitating Disorders
October 15, 2020 08:30 ET | Cybin Corp.
NEW YORK, Oct. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — Cybin Corp. today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ brands in the...
Cybin LOGO.png
Cybin Corp. CEO Discusses Ongoing Efforts to Develop One of the First Commercially Approved Psychedelic Medications for Mental Health
September 15, 2020 08:30 ET | Cybin Corp.
NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio — Cybin Corp. today announces that its chief executive officer, Doug Drysdale, is featured in an exclusive audio interview with...